Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 5001 - 5020 of 18628
Early Termination Notices

20141617: Nucor Corporation; Gerdau S.A.

… Notice 20141617: Nucor Corporation; Gerdau S.A. 20141617 Dofasco Gallatin LLC Co-Steel C.S.M. Corp. Dofasco Wyoming Inc. Co-Steel/Dofasco, LLC Gerdau S.A. Nucor Corporation … 20141617: Nucor …
Date
Acquiring Party
Nucor Corporation
Acquired Party
Gerdau S.A.
Acquired Entities
Dofasco Gallatin LLC
Co-Steel C.S.M. Corp.
Dofasco Wyoming Inc.
Co-Steel/Dofasco, LLC
Early Termination Notices

20141616: Nucor Corporation; ArcelorMittal

… Notice 20141616: Nucor Corporation; ArcelorMittal 20141616 Dofasco Gallatin LLC Dofasco Wyoming Inc. Co-Steel C.S.M. Corp. Co-Steel/Dofasco, LLC ArcelorMittal Nucor Corporation … 20141616: …
Date
Acquiring Party
Nucor Corporation
Acquired Party
ArcelorMittal
Acquired Entities
Dofasco Gallatin LLC
Dofasco Wyoming Inc.
Co-Steel C.S.M. Corp.
Co-Steel/Dofasco, LLC
HSR Informal Interpretations

1409005 Informal Interpretation

… 10:05 AM To: (Redacted) Subject: RE: Item 5 question If the assets constituted an operating unit, as defined in … did not exist in 2013. It was formed in 2014 and the assets of an existing business were put into it. That business (but …
Date
Rule
802.1(a)
If the assets constituted an operating unit, as defined in §802.1(a), the revenues it generated in 2013 should be reported.
Rules

Advertising Allowances and Other Merchandising Payments and Services ("Fred Meyer Guides")

… Advertising Allowances and Other Merchandising Payments and Services ("Fred Meyer Guides") Advertising Allowances and Other Merchandising Payments and Services ("Fred Meyer …
Rule Updated Date
The Fred Meyer Guides explain to manufacturers and wholesalers how they can provide advertising and promotional allowances and services to retailers without price discrimination and on “proportionally...
Text of Rule
Early Termination Notices

20141608: WSP Global Inc.; Balfour Beatty plc

… Global Inc.; Balfour Beatty plc 20141608 Parsons Brinckerhoff Romania SRL Parsons Brinckerhoff Group Employment Limited Parsons Brinckerhoff Halsall Inc. fka Halsall Associates Ltd Balfour Beatty & …
Date
Acquiring Party
WSP Global Inc.
Acquired Party
Balfour Beatty plc
Acquired Entities
Parsons Brinckerhoff Romania SRL
Parsons Brinckerhoff Group Employment Limited
Parsons Brinckerhoff Halsall Inc. fka Halsall Associates Ltd
Balfour Beatty & Parsons Brinckerhoff Australia LP
Parsons Brinckerhoff Holdings Mauritius Limited
Parsons Brinckerhoff Muhendislik A.S.
Parsons Brinckerhoff Holdings Inc.
Parsons Brinckerhoff (Asia) Ltd.
Parsons Brinckerhoff International Pte. Ltd.
Parsons Brinckerhoff Ltd
Ingenieurgesellschaft fur Verkehrsplanung
Parsons Brinckerhoff Middle East Ltd.
Advocacy Filings

Federal Trade Commission Comment Before the Federal Communications Commission Regarding the Privacy and Security Practices of Broadband Providers and Their Impact On Broadband Adoption

… Federal Trade Commission Comment Before the Federal Communications Commission Regarding the Privacy and Security Practices of Broadband Providers and Their Impact On Broadband …
Date
The FTC filed a comment before the Federal Communications Commission (FCC) in response to its inquiry into the status of broadband availability and deployment to all Americans, in which the FCC asked...
Related Release
FTC Provides Comment to Federal Communications Commission on Consumer Privacy and Data Security Issues and Broadband Internet Services
Cases and Proceedings

Akorn, Inc., In the Matter of

… Akorn, Inc., In the Matter of Akorn, Inc., In the Matter of Akorn, Inc. has agreed to sell its rights to …

Akorn, Inc. has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s proposed acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would likely be anticompetitive. According to the FTC’s complaint, only VersaPharm and two other firms currently have FDA approval to sell generic injectable rifampin and there are no viable substitutes for rifampin as a course of treatment for tuberculosis. The FTC’s proposed settlement with Akorn requires the company to divest its Abbreviated New Drug Application for generic injectable rifampin – which is currently pending before the Food and Drug Administration – to Watson Laboratories, Inc.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
141 0162
Displaying 5001 - 5020 of 18628
Return to top